The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer-reviewed. In the first study to describe the magnitude of coronary microvascular collateral ...
The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
Please provide your email address to receive an email when new articles are posted on . Teleflex’s percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) ...
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
DENVER, April 22, 2022 – A new study examines the effect of rapid infusion of 2meq/kg of sodium bicarbonate (NaHCO3) in an ovine model on gas exchange and coronary and cerebral perfusion in the ...
The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, ...
TCT 918: The Widening Impact of Coronary Artery Disease on Sudden Death and Cardiac Arrest Mortality: A Population-Based Observational Study (1999-2023) Receive the the latest news, research, and ...
Philips (NYSE: PHG) announced today that it received FDA 510(k) clearance for its SmartHeart planning solution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results